Point72 Asset Management’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-76,958
Closed -$1.1M 3997
2025
Q3
$1.1M Buy
+76,958
New +$1.08M ﹤0.01% 1665
2023
Q1
Sell
-24,600
Closed -$239K 2354
2022
Q4
$239K Sell
24,600
-178,000
-88% -$1.92M ﹤0.01% 1241
2022
Q3
$2.35M Sell
202,600
-28,700
-12% -$362K 0.01% 897
2022
Q2
$2.31M Sell
231,300
-41,200
-15% -$535K 0.01% 906
2022
Q1
$4.98M Sell
272,500
-38,500
-12% -$680K 0.02% 708
2021
Q4
$7.26M Buy
+311,000
New +$6.83M 0.03% 594

Other funds holding GHRS

Point72 Asset Management's GHRS Position: Q4 2025 in Review

Point72 Asset Management sold out of GH Research (GHRS) in Q4 2025, closing a stake of 76,958 shares — an estimated $1.1M sold.

Point72 Asset Management first reported a position in GHRS in Q4 2021 and held it in 6 quarters. The position peaked at $7.26M in Q4 2021. 53 funds tracked by Wall St. Rank hold GHRS as of Q4 2025.

  • Point72 Asset Management reported no remaining GH Research position as of Q4 2025 after selling out during the quarter.
  • Point72 Asset Management sold 76,958 GH Research shares in Q4 2025, an estimated $1.1M.
  • Point72 Asset Management first reported a position in GH Research in Q4 2021 and held it in 6 quarters.
  • Point72 Asset Management's GH Research position peaked at $7.26M in Q4 2021.
  • 53 funds tracked by Wall St. Rank held GH Research as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.